Our Transactions
Leadership across the largest and most complex situations
Financial Advisor
![]()
$12.8 billion merger with
![]()
2025
Financial Advisor
$7.4 billion acquisition of

2025
Financial Advisor

separation into two publicly traded companies
2025
Financial Advisor

pending ~$34.5 billion merger with

2025
Lead Financial Advisor
![]()
$12 billion sale of a portfolio of natural gas generation facilities and a virtual power plant platform to

2025
Financial Advisor

in connection with its intent to separate

into a standalone public company
2025
Financial Advisor

separation of its Biosciences & Diagnostics Solutions business
2025
Lead Financial Advisor

pending $29.1 billion sale to

2025
Financial Advisor

$5.1 billion
sale to

2024
|
Anouncement Date1 |
Status |
Transaction |
Value (M) |
|---|---|---|---|
|
November 5, 2025 |
Closed |
Active bookrunner on Benitec Biopharma’s underwritten public offering and registered direct offering |
$100 |
|
November 3, 2025 |
Pending |
Advising SM Energy on its merger with Civitas Resources |
$12,800 |
|
October 31, 2025 |
Pending |
Advising Palomar on its acquisition of The Gray Casualty & Surety Co. |
$300 |
|
October 29, 2025 |
Pending |
Advising EquityZen on its sale to Morgan Stanley |
N/A |
|
October 29, 2025 |
Pending |
Advising Clario on its sale to Thermo Fisher |
~$9,000 |
|
October 27, 2025 |
Pending |
Advising KKR in partnership with Apollo on its joint investment in Keurig Dr Pepper |
~$7,000 |
|
October 27, 2025 |
Pending |
Advising Huntington Bancshares Inc. on its acquisition of Cadence Bank |
$7,400 |
|
October 22, 2025 |
Closed |
Advised Woodside on its strategic LNG partnership with Williams |
$1,900 |
|
October 16, 2025 |
Closed |
Active Bookrunner on Standard Lithium’s upsized equity offering |
$130 |
|
October 14, 2025 |
Pending |
Advising Astria Therapeutics on its sale to BioCryst |
~$920 |
|
October 10, 2025 |
Pending |
Advising Carlyle on its acquisition of BASF Coatings |
€7,700 |
|
October 6, 2025 |
Closed |
Advised ECI Partners on its continuation fund for CSL Group |
N/A |
|
October 2, 2025 |
Closed |
Advised PAI on its continuation fund to support the continued ownership of Froneri |
~€3,600 |
|
October 1, 2025 |
Pending |
Advising CyberCube on its investment from Spectrum Equity |
N/A |
|
September 25, 2025 |
Closed |
Acted as exclusive global placement agent for Ridgemont Equity Partners’ Fund V |
$3,975 |
|
September 22, 2025 |
Pending |
Advising Thoma Bravo on its acquisition of PROS Holdings |
$1,400 |
|
September 18, 2025 |
Pending |
Advising Inigo Ltd. on its sale to Radian Group |
$1,700 |
|
September 17, 2025 |
Pending |
Advising Nasdaq on its sale of Solovis to Insight Partners |
N/A |
|
September 15, 2025 |
Pending |
Advising AmTrust on its carve-out of its MGA businesses |
N/A |
|
September 12, 2025 |
Closed |
Advised CityFibre on its comprehensive £6.2bn recapitalization, including £2.3bn of incremental debt and equity facilities |
~£6,200 |
|
September 11, 2025 |
Closed |
Acted as joint bookrunner in Gemini Space Station’s initial public offering |
$446 |
|
September 11, 2025 |
Pending |
Advising Technip Energies on its acquisition of Ecovyst’s AM&C Business |
$556 |
|
September 11, 2025 |
Closed |
Advised Dianthus Therapeutics on its upsized follow-on offering |
$288 |
|
September 10, 2025 |
Pending |
Advising Gemini Financial on its sale to SageSure |
N/A |
|
September 9, 2025 |
Closed |
Advised DeepIntent on its sale of a majority interest to Vitruvian |
$637 |
|
September 4, 2025 |
Pending |
Advising Hexagon on the sale of its design & engineering business (MSC Software) to Cadence |
€2,700 |
|
September 3, 2025 |
Closed |
Advised an ad hoc group of lenders in the sale of substantially all of Sunnova’s assets |
N/A |
|
September 3, 2025 |
Pending |
Advising Apollo Group Holdings on its sale to Skyward Specialty Insurance Group |
$555 |
|
August 26, 2025 |
Pending |
Advising Invesco on the sale of Intelliflo to Carlyle |
Up to $200mm |
|
August 21, 2025 |
Pending |
Advising Dayforce on its sale to Thoma Bravo |
$12,300 |
|
August 21, 2025 |
Pending |
Advising Interius Biotherapeutics on its sale to Kite Pharma |
$350 |
|
August 14, 2025 |
Pending |
Advising Aramco on a landmark lease-and-leaseback transaction for its Jafurah midstream assets, with an international consortium led by GIP, a part of BlackRock |
$11,000 |
|
August 12, 2025 |
Pending |
Advising Prothya on its sale to Accord Healthcare |
N/A |
|
August 8, 2025 |
Closed |
Acted as lead structuring advisor and lead bookrunner on AlpInvest’s issuance of a collateralized fund obligation |
$1,250 |
|
August 5, 2025 |
Pending |
Advising Shelf Drilling on the announced recommended offer by ADES International Holding to acquire all outstanding shares of Shelf Drilling by way of a cash merger |
~$1,600 |
|
August 5, 2025 |
Pending |
Advising Elite on its sale to Francisco Partners |
N/A |
|
August 4, 2025 |
Pending |
Advising CommScope on the sale of its Connectivity and Cable Solutions business to Amphenol |
$10,500 |
|
July 31, 2025 |
Pending |
Advising Just Group on its recommended cash offer by Brookfield |
£2,364 |
|
July 18, 2025 |
Pending |
Advising EQT Partners on the acquisition of Adalvo |
N/A |
|
July 15, 2025 |
Pending |
Advising The Sterling Group on its acquisition of a majority ownership stake in Precision Concepts International from ONCAP |
N/A |
|
July 14, 2025 |
Pending |
Advising BD on the combination of its Biosciences and Diagnostic Solutions business with Waters in a Reverse Morris Trust |
$17,500 |
|
July 14, 2025 |
Closed |
Advising Huntington Bancshares Inc. on its acquisition of Veritex Holdings |
~$1,900 |
|
July 1, 2025 |
Closed |
Acted as a lead sales agent in D-Wave Quantum’s at-the-market offering |
~$400 |
|
June 26, 2025 |
Pending |
Advising Inspired PLC on its recommended sale to HGGC |
£184 |
|
June 24, 2025 |
Pending |
Advising Harvest on its Growth Investment in Med-Metrix |
N/A |
|
June 18, 2025 |
Pending |
Acting as joint bookrunner in Caris Life Sciences’ initial public offering |
$494 |
|
June 17, 2025 |
Pending |
Advising Lee Equity Partners on its acquisition of Shackleton |
N/A |
|
June 16, 2025 |
Pending |
Advising Mavenir Systems on its comprehensive recapitalization |
N/A |
|
June 10, 2025 |
Pending |
Advising SIFI and 21 Invest SGR on the sale of SIFI to Faes Farma |
Up to ~€355 |
|
June 9, 2025 |
Pending |
Advising Warner Bros. Discovery on its separation into two publicly traded companies |
N/A |
|
June 9, 2025 |
Pending |
Advising Qualcomm on its recommended acquisition of Alphawave IP Group |
~$2,400 |
|
June 9, 2025 |
Pending |
Advising Baker Hughes Co. on the sale of their PSI business to Crane Co. |
$1,150 |
|
June 6, 2025 |
Pending |
Acting as joint bookrunner on Omada Health’s initial public offering |
$150 |
|
June 2, 2025 |
Closed |
Advised Antares Capital on its multi-asset credit continuation fund |
$1,200 |
|
May 28, 2025 |
Closed |
Acted as joint bookrunner for Birkenstock’s follow-on offering |
$941 |
|
May 28, 2025 |
Pending |
Advising SunCoke Energy on its acquisition of Phoenix Global |
$325 |
|
May 28, 2025 |
Pending |
Advising SkyNRG on its investment from APG, MAM and KLM |
€300 |
|
May 27, 2025 |
Pending |
Advising an ad hoc group of crossholders on Astound Broadband’s recapitalization |
$5,600 |
|
May 22, 2025 |
Closed |
Acted as joint bookrunner for Hinge Health’s initial public offering |
$503 |
|
May 19, 2025 |
Pending |
Advising Finastra and Vista Equity Partners on the sale of Finastra’s treasury and capital markets division to Apax Partners |
N/A |
|
May 19, 2025 |
Closed |
Advised Inflexion Private Equity Partners on its multi-asset continuation fund |
~£2,300 |
|
May 16, 2025 |
Closed |
Advised VIA equity on its continuation fund to acquire Continia Software |
N/A |
|
May 16, 2025 |
Pending |
Advising Cox Communications on its merger with Charter Communications |
~$34,500 |
|
May 15, 2025 |
Pending |
Advising Foot Locker on its sale to Dick's Sporting Goods |
$2,500 |
|
May 14, 2025 |
Pending |
Advising GSK on its acquisition of efimosfermin from Boston Pharmaceuticals |
Up to ~$2,000 |
|
May 14, 2025 |
Pending |
Advising WuXi Bioligics on the sale of its Leverkusen drug product manufacturing facility |
€150 |
|
May 13, 2025 |
Closed |
Advised JMG Group on its strategic investment from Synova and GTCR |
N/A |
|
May 12, 2025 |
Pending |
Advising LS Power on the sale of a portfolio of natural gas generation facilities and a virtual power plant platform to NRG Energy |
$12,000 |
|
May 9, 2025 |
Pending |
Advising the special committee of the board of directors of TaskUs on its take-private by Blackstone and the company’s co-founders |
N/A |
|
May 6, 2025 |
Pending |
Advising Peppertree Capital Management on its sale to TPG |
Up to ~$960 |
|
April 30, 2025 |
Pending |
Acting as exclusive financial advisor to Regulus Therapeutics on its sale to Novartis |
Up to ~$1,700 |
|
April 30, 2025 |
Pending |
Advising IPL on its merger with Schoeller Allibert |
N/A |
|
April 29, 2025 |
Pending |
Advising S&P Global in connection with its intent to separate its mobility segment into a standalone public company |
N/A |
|
April 29, 2025 |
Pending |
Advising Omada on its sale to GRO Capital and Kirk Capital |
N/A |
|
April 16, 2025 |
Pending |
Advising NorthC and a UK DC business on the acquisition of a portfolio of eight data center facilities from Colt Technology Services |
N/A |
|
April 14, 2025 |
Pending |
Advising Capital Power on its acquisition of Hummel and Rolling Hills power generation assets |
~$2,200 |
|
April 14, 2025 |
Pending |
Advising an ad hoc group of first-lien term loan holders on Cision’s recapitalization |
$2,400 |
|
April 10, 2025 |
Closed |
Advised U.S. Steel on its activism defense against Ancora |
N/A |
|
April 10, 2025 |
Closed |
Advised Litmus Software on its sale to Validity |
N/A |
|
April 9, 2025 |
Pending |
Advising HealthEdge on its sale to Bain Capital |
N/A |
|
April 9, 2025 |
Pending |
Advising EQT on the sale of a minority stake in IFS to ADIA, CPP, and Hg |
N/A |
|
April 8, 2025 |
Closed |
Advised Bausch Health Companies on the launch of its new senior secured credit facilities and senior secured notes |
$7,900 |
|
April 7, 2025 |
Pending |
Advising CVC DIF on its acquisition of a 49% interest in Balance Erneuerbare Energien |
N/A |
|
April 7, 2025 |
Pending |
Advising Woodside Energy on its sale of a 40% interest in Louisiana LNG Infrastructure to Stonepeak |
$5,700 |
|
April 3, 2025 |
Pending |
Advising the shareholders of Colonial Enterprises on its sale to Brookfield Infrastructure Partners |
~$9,000 |
|
April 2, 2025 |
Pending |
Advising Southern Water on its forward starting backstop facility and swap maturity extension |
£1,200 |
|
April 2, 2025 |
Pending |
Advising Dotmatics on its sale to Siemens |
$5,100 |
|
March 31, 2025 |
Pending |
Advising Preem on its sale to VARO Energy |
N/A |
|
March 27, 2025 |
Pending |
Advising Excelerate Energy on its acquisition of New Fortress Energy’s downstream LNG and Power Infrastructure business in Jamaica |
$1,055 |
|
March 19, 2025 |
Pending |
Advising Ampere Computing on its sale to SoftBank |
$6,500 |
|
March 19, 2025 |
Pending |
Advising T&D Holdings on its investment into Viridium, as part of a consortium including Allianz and BlackRock |
€3,500 |
|
March 19, 2025 |
Pending |
Advising OptiNose on its sale to Paratek Pharmaceuticals |
~$330 |
|
March 12, 2025 |
Closed |
Advised Appriss Retail on its sale to Gemspring Capital |
N/A |
|
March 12, 2025 |
Closed |
Acted as an active bookrunner on Mineralys’ follow-on offering |
$175 |
|
March 12, 2025 |
Closed |
Advised Phi Industrial Acquisitions on a continuation fund for BlueSun HoldCo |
€287 |
|
March 12, 2025 |
Closed |
Advised Phi Industrial on its continuation fund to acquire BlueSun HoldCo |
€287 |
|
March 10, 2025 |
Closed |
Advised Fundare Resources Company on the sale of its subsidiary, Moonrise Midstream, to Summit Midstream Corporation |
$90 |
|
March 6, 2025 |
Closed |
Advised Crestview Partners on its acquisition of Smyth Companies |
N/A |
|
March 6, 2025 |
Closed |
Advised Smooth-Bor on its sale to Plastiflex Group |
N/A |
|
March 5, 2025 |
Closed |
Acted as joint-placement agent to Lithium Americas on its convertible note PIPE investment from Orion Resource Partners |
$250 |
|
March 5, 2025 |
Pending |
Advising CoreWeave on its acquisition of Weights & Biases |
N/A |
|
March 3, 2025 |
Pending |
Advising Buckman Laboratories on its sale to Pritzker Private Capital |
N/A |
|
March 3, 2025 |
Closed |
Acted as co-manager to Synopsys on its senior notes offering to support the acquisition of Ansys |
$10,000 |
|
March 3, 2025 |
Pending |
Advising Keysight on the sale of Spirent’s high-speed Ethernet and network security business |
$425 |
|
February 25, 2025 |
Pending |
Advising LongRange Capital on its acquisition of U.S. Synthetic from ChampionX |
$300 |
|
February 24, 2025 |
Pending |
Advising Alat on its acquisition of a minority stake in TK Elevator and establishment of a KSA-based joint venture |
N/A |
|
February 21, 2025 |
Pending |
Advising ConocoPhillips on the sale of its interest in deepwater U.S. oil and gas assets to Shell |
$735 |
|
February 18, 2025 |
Closed |
Acted as an Active Bookrunner on Arcus Biosciences’ registered direct offering |
$150 |
|
February 12, 2025 |
Pending |
Advising Riot Platforms on AI/HPC uses for its power assets at its facilities |
N/A |
|
February 12, 2025 |
Closed |
Acted as placement agent and financial advisor to Super Micro Computer on its convertible private placement and convertible note amendment |
$2,425 |
|
February 12, 2025 |
Closed |
Acted as an active bookrunner on Karman Space & Defense’s upsized initial public offering |
$582 |
|
February 12, 2025 |
Closed |
Acted as lead left bookrunner on Zurn Elkay Water Solutions’ follow-on offering |
$312 |
|
February 12, 2025 |
Closed |
Acted as an active bookrunner on Sailpoint’s initial public offering |
$1,380 |
|
February 10, 2025 |
Pending |
Advising Hg on the sale of its majority stake in Trackunit to Goldman Sachs Alternatives |
N/A |
|
February 10, 2025 |
Pending |
Advising Kito Crosby on its sale to Columbus McKinnon |
$2,700 |
|
February 6, 2025 |
Pending |
Advising Zips Car Wash on its pre-arranged chapter 11 restructuring |
~$950 |
|
February 6, 2025 |
Closed |
Advising Rocktree Logistics Group on its acquisition of ATRIA Soluciones Logísticas and new $350mm credit facility from an affiliate of EnTrust Global |
N/A |
|
February 5, 2025 |
Pending |
Advising Becton Dickinson on the separation of its biosciences & diagnostics solutions business |
N/A |
|
January 30, 2025 |
Closed |
Acted as an active bookrunner on Metsera’s initial public offering |
$316 |
|
January 30, 2025 |
Pending |
Advising Viper Energy on its definitive purchase and sale agreement to acquire equity interests in certain mineral and royalty-interest owning subsidiaries of Diamondback |
~$4,450 |
|
January 29, 2025 |
Pending |
Advised Henry Schein on its activism defense against Ananym and a strategic investment by KKR |
N/A |
|
January 27, 2025 |
Pending |
Advising Evelyn Partners on the sale of its Evelyn Partners Fund Solutions business to Thesis Holdings |
N/A |
|
January 23, 2025 |
Pending |
Advising HTC Partners on the partial sale of its extended reality (XR) unit to Google |
$250 |
|
January 21, 2025 |
Closed |
Advised Ares as preferred lender and sponsor of the company’s out-for-court recapitalization |
~$1,400 |
|
January 17, 2025 |
Pending |
Advising Better Health Group on its new money financing and debt exchange transaction |
~$843 |
|
January 17, 2025 |
Pending |
Advising WuXi AppTec on the sale of its U.S medical device testing operations to NAMSA |
N/A |
|
January 16, 2025 |
Pending |
Advising Infinidat on its sale to Lenovo |
N/A |
|
January 15, 2025 |
Closed |
Acted as an active bookrunner on Flowco’s initial public offering |
$491 |
|
January 14, 2025 |
Closed |
Advised EMCOR Group on its acquisition of Miller Electric |
$865 |
|
January 14, 2025 |
Closed |
Advised Hivest Capital Partners on a continuation fund to acquire interests in Agora Makers |
N/A |
|
January 13, 2025 |
Closed |
Acted as lead global placement agent for the fundraise of Hildred Capital’s Fund III |
$810 |
|
January 10, 2025 |
Pending |
Advising Calpine on its sale to Constellation Energy |
$29,100 |
|
January 10, 2025 |
Pending |
Advising Alliance Pharma on its recommended acquisition from DBAY Advisors |
£350 |
|
January 10, 2025 |
Pending |
Advising RP Management on its sale to Royalty Pharma |
~$1,100 |
|
January 8, 2025 |
Pending |
Advising Transcarent on its acquisition of Accolade |
$621 |
|
January 6, 2025 |
Pending |
Advising FuboTV on its business combination with Walt Disney’s Hulu + Live TV vMVPD business |
N/A |
|
January 3, 2025 |
Closed |
Advised Nu Skin on the sale of its Mavely business to Later |
~250 |
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.
